SHSE:688581 (China)
Â
Ordinary Shares - Class A
Â¥
53.6
-2.1 (-3.77%)
Jul 17
Business Description
Hangzhou AGS Medtech Co Ltd
ISIN : CNE100005ZF0
Share Class Description:
SHSE:688581: Ordinary Shares - Class ATotal Employee Number:
807Compare
Compare
Traded in other countries / regions
688581.China Index Membership
SSE Composite Index IPO Date
2023-05-19Description
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 62.05 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 1421.87 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 23 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.4 | |||||
3-Year EBITDA Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | -0.8 | |||||
3-Year FCF Growth Rate | -11.8 | |||||
3-Year Book Growth Rate | 70.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.54 | |||||
9-Day RSI | 59.57 | |||||
14-Day RSI | 54.66 | |||||
3-1 Month Momentum % | -1.23 | |||||
6-1 Month Momentum % | -12.92 | |||||
12-1 Month Momentum % | -16.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 17.48 | |||||
Quick Ratio | 17.03 | |||||
Cash Ratio | 16.54 | |||||
Days Inventory | 123.39 | |||||
Days Sales Outstanding | 32.74 | |||||
Days Payable | 93.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.96 | |||||
Dividend Payout Ratio | 0.5 | |||||
Forward Dividend Yield % | 1.96 | |||||
5-Year Yield-on-Cost % | 1.96 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 1.59 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.78 | |||||
Operating Margin % | 37.1 | |||||
Net Margin % | 36.7 | |||||
EBITDA Margin % | 43.47 | |||||
FCF Margin % | 21.88 | |||||
OCF Margin % | 33.33 | |||||
ROE % | 8.92 | |||||
ROA % | 8.44 | |||||
ROIC % | 25.5 | |||||
3-Year ROIIC % | 7.5 | |||||
ROC (Joel Greenblatt) % | 94.23 | |||||
ROCE % | 10.53 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.42 | |||||
Forward PE Ratio | 11.33 | |||||
PE Ratio without NRI | 19.45 | |||||
Price-to-Owner-Earnings | 24.64 | |||||
PEG Ratio | 0.96 | |||||
PS Ratio | 7.13 | |||||
PB Ratio | 1.69 | |||||
Price-to-Tangible-Book | 1.72 | |||||
Price-to-Free-Cash-Flow | 32.52 | |||||
Price-to-Operating-Cash-Flow | 21.4 | |||||
EV-to-EBIT | 8.83 | |||||
EV-to-EBITDA | 8.83 | |||||
EV-to-Revenue | 3.84 | |||||
EV-to-FCF | 17.54 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.13 | |||||
Price-to-Graham-Number | 1.22 | |||||
| Price-to-Net-Current-Asset-Value | 2.22 | |||||
| Price-to-Net-Cash | 2.35 | |||||
Earnings Yield (Greenblatt) % | 11.33 | |||||
FCF Yield % | 3.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou AGS Medtech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 605.583 | ||
| EPS (TTM) (Â¥) | 2.76 | ||
| Beta | 1.2644 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 39.11 | ||
| 14-Day RSI | 54.66 | ||
| 14-Day ATR (Â¥) | 2.034843 | ||
| 20-Day SMA (Â¥) | 53.373 | ||
| 12-1 Month Momentum % | -16.14 | ||
| 52-Week Range (Â¥) | 49 - 88.96 | ||
| Shares Outstanding (Mil) | 80.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou AGS Medtech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou AGS Medtech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 1.039000 Cash Dividend | 2026-06-17 | 55.49 (+0.16%) | ||
| CNY 1.373500 Cash Dividend | 2025-07-09 | 65.01 (+1.63%) | ||
| 1.4:1 Stock Split | 2024-06-21 | 54.85 (+0.63%) |
Show
Entries
Hangzhou AGS Medtech Co Ltd Frequently Asked Questions
What is Hangzhou AGS Medtech Co Ltd(SHSE:688581)'s stock price today?
The current price of SHSE:688581 is ¥53.60. The 52 week high of SHSE:688581 is ¥88.96 and 52 week low is ¥49.00.
When is next earnings date of Hangzhou AGS Medtech Co Ltd(SHSE:688581)?
The next earnings date of Hangzhou AGS Medtech Co Ltd(SHSE:688581) is .
Does Hangzhou AGS Medtech Co Ltd(SHSE:688581) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou AGS Medtech Co Ltd(SHSE:688581) is 1.96% (As of Today), Highest Dividend Payout Ratio of Hangzhou AGS Medtech Co Ltd(SHSE:688581) was 0.58. The lowest was 0.19. And the median was 0.43. The  Forward Dividend Yield % of Hangzhou AGS Medtech Co Ltd(SHSE:688581) is 1.96%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hangzhou AGS Medtech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers